DANIEL KIERNAN, MD
Ophthalmology Physician · SARASOTA, FL
Individual Active NPI 1376790022
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 980 | 38,831 | $12,507,173 | $5,155,252 | $4,070,900 |
| 2023 | 653 | 25,607 | $7,783,358 | $3,534,527 | $2,788,727 |
| 2022 | 566 | 10,491 | $4,784,937 | $2,617,756 | $2,068,469 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 17,760 | $34 | $27 |
| J0177 | Injection, aflibercept hd, 1 mg | 3,816 | $310 | $247 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 3,200 | $108 | $86 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 3,030 | $148 | $118 |
| 92134 | Imaging of retina | 2,284 | $39 | $29 |
| 67028 | Injection of drug into eye | 1,638 | $130 | $100 |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 1,600 | $1 | $1 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,549 | $129 | $92 |
| J0178 | Injection, aflibercept, 1 mg | 1,144 | $821 | $654 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 355 | $25 | $17 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 280 | $202 | $161 |
| J3590 | Unclassified biologics | 238 | $2,685 | $2,134 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 261453 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Florida
- NPI 1588114730
- NPI 1104288547
- NPI 1255377305
- NPI 1598955049
- NPI 1710374814
- NPI 1730183005
- NPI 1548656960
- NPI 1285636365
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.